v3.21.1
Statements of Cash Flows - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:        
Net income $ 10,719,999 $ 0 $ (28,890,395) $ 0
Adjustments to reconcile net income to net cash used in operating activities:        
Trust account interest income (18,917) 0 (78,624) 0
Change in fair value of warrant derivative liability (11,210,000) 0 27,690,000 0
Changes in operating assets and liabilities:        
Decrease (increase) in prepaid expenses (13,877) 0 (105,838) 0
Increase (decrease) in accounts payable and accrued liabilities (55,135) 0 127,450 0
Net cash used in operating activities (577,930) 0 (1,257,407) 0
Cash flows from investing activities:        
Cash withdrawn from trust account for tax payments 71,388 0    
Net cash used in investing activities 71,388 0 (500,000,000) 0
Cash flows from financing activities:        
Proceeds from public offering     500,000,000 0
Proceeds from sale of private placement warrants     12,000,000 0
Payment for underwriting discounts     (8,953,885) 0
Payment of offering costs     (606,622) 0
Payment of notes payable, affiliates     (166,750) 0
Proceeds from stock subscriptions receivable, affiliates     2,070 0
Net cash provided by financing activities 0 0 502,274,813 0
Net increase (decrease) in cash and cash equivalents (506,542) 0 1,017,406 0
Cash and cash equivalents at beginning of period 1,017,406 0 0 0
Cash and cash equivalents at end of period 510,864 0 1,017,406 0
Statement of Cash Flows:        
Change in value of common shares subject to possible conversion $ 10,719,999 $ 0 (26,989,759) 0
Initial classification of common shares subject to possible conversion     449,844,167 0
Deferred underwriting commissions     17,500,000 0
Initial warrant derivative liability     28,030,000 0
Offering costs included in Notes payable, affiliates     $ 166,750 $ 0